Press Releases
Press Releases
Twelve months ended 31 December 2024.
FY24 revenue
Organic revenue growth1
Price and volume/mix
Organic operating profit growth
Increase in total FY24 dividend
FY25 organic revenue growth guidance2
Allocation for share buybacks in 2025
I am pleased with our performance in 2024 and the progress we are making to build Haleon into an agile, competitive and consumer-focused organisation. We are delivering against our growth plans, achieving 5.0% organic revenue growth for the year with organic profit growth ahead of this at 9.8%. Importantly, 71% of our business gained or maintained share in the year, demonstrating the strength and appeal our brands continue to have with consumers around the world.
Sensodyne Clinical White
#1 innovation in the US Oral Health market and is now available in over 10 markets.
parodontax Gum Strengthen & Protect with hyaluronic acid was launched in several markets in EMEA.
In Southern and Eastern Europe, we launched Poligrip Ultimate All in One, featuring our Ultimate Biting Power Technology.
We launched our new Panadol Dual Action combination of ibuprofen and paracetamol.
In the US, we launched Theraflu-D Flu Relief Max Strength Syrups, containing pseudoephedrine.
We expanded our Centrum range in Brazil to include single sachets to help drive accessibility among low-income consumer groups.
We introduced Emergen-C Crystals Immune+, a new formula which contains vitamin D.
Sensodyne
Voltaren
Centrum
Parodontax
Advil
Otrivin
Polident
Sensodyne
Theraflu
References:
1. Organic revenue growth and adjusted operating profit are non-IFRS measures; definitions and calculations of non-IFRS measures can be found in our stock exchange announcement.
2. Definitions of organic revenue growth and adjusted operating profit can be found in our stock exchange announcement.
3. Market share statements throughout this report are estimates based on the Group’s analysis of third party market data of revenue for YTD Nov 2024 including IQVIA, IRI and Nielsen data. Represents % of brand-market combinations gaining or maintaining share (this analysis covers c.90% of Haleon’s total revenue).